Pantelis A Sarafidis
Overview
Explore the profile of Pantelis A Sarafidis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
175
Citations
2548
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iatridi F, Theodorakopoulou M, Georgiou A, Sarafidis P
J Hypertens
. 2025 Feb;
43(4):720-721.
PMID: 39995226
No abstract available.
2.
Theodorakopoulou M, Ortiz A, Fernandez-Fernandez B, Kanbay M, Minutolo R, Sarafidis P
Clin Kidney J
. 2024 Nov;
17(Suppl 2):36-50.
PMID: 39583143
Until recently, major bodies producing guidelines for the management of hypertension in patients with chronic kidney disease (CKD) disagreed in some key issues. In June 2023, the European Society of...
3.
Pella E, Boutou A, Boulmpou A, Theodorakopoulou M, Karagiannidis A, Haddad N, et al.
Int Urol Nephrol
. 2024 Oct;
57(3):897-906.
PMID: 39467956
Purpose: Heart failure (HF) and atrial fibrillation (AF) are highly prevalent in hemodialysis. They are well-known significant modifiers of the disease associations with cardiovascular outcomes, but there is a lack...
4.
Karagiannidis A, Iatridi F, Sarafidis P
J Hum Hypertens
. 2024 Aug;
38(9):629-630.
PMID: 39191910
No abstract available.
5.
Mayer C, Sarafidis P, Matschkal J, Theodorakopoulou M, Lorenz G, Karagiannidis A, et al.
Clin Kidney J
. 2024 Jul;
17(7):sfae172.
PMID: 39056069
Background: Risk prediction in haemodialysis (HD) patients is challenging due to the impact of the dialysis regime on the patient's volume status and the complex interplay with cardiac function, comorbidities...
6.
Heerspink H, Agarwal R, Bakris G, Cherney D, Lam C, Neuen B, et al.
Nephrol Dial Transplant
. 2024 Jun;
40(2):308-319.
PMID: 38858818
Background: Finerenone, a non-steroidal mineralocorticoid receptor antagonist, improved kidney and cardiovascular outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes in two phase 3 outcome trials. The...
7.
Karagiannidis A, Theodorakopoulou M, Pella E, Sarafidis P, Ortiz A
Nephrol Dial Transplant
. 2024 Jan;
39(7):1073-1087.
PMID: 38211973
Uromodulin is a kidney-specific glycoprotein which is exclusively produced by the epithelial cells lining the thick ascending limb and early distal convoluted tubule. It is currently recognized as a multifaceted...
8.
Faitatzidou D, Karagiannidis A, Theodorakopoulou M, Xanthopoulos A, Triposkiadis F, Sarafidis P
Am J Nephrol
. 2023 Oct;
55(1):37-55.
PMID: 37788657
Background: In patients with end-stage kidney disease (ESKD) receiving peritoneal dialysis (PD), cardiovascular events represent the predominant cause of morbidity and mortality, with cardiac arrhythmias and sudden death being the...
9.
Rojas-Rivera J, Bakkaloglu S, Bolignano D, Nistor I, Sarafidis P, Stoumpos S, et al.
Nephrol Dial Transplant
. 2023 Jul;
39(1):151-158.
PMID: 37433583
Chronic kidney disease (CKD) is diagnosed when glomerular filtration rate (GFR) falls below 60 ml/min/1.73 m2 or urinary albumin:creatinine ratio (UACR) reaches ≥30 mg/g, as these two thresholds indicate a...
10.
Sarafidis P, Theodorakopoulou M, Ortiz A, Fernandez-Fernandez B, Nistor I, Schmieder R, et al.
Nephrol Dial Transplant
. 2023 May;
38(12):2835-2850.
PMID: 37202218
Atherosclerotic renovascular disease (ARVD) is the most common type of renal artery stenosis. It represents a common health problem with clinical presentations relevant to many medical specialties and carries a...